Leqembi

Soleo Health Selected as Sole Specialty Pharmacy Distributor of Newly FDA-Approved Alzheimer’s Treatment

by | Jan 18, 2023
Frisco-based pharmacy services provider Soleo Health has been selected by Eisai Inc. as the sole specialty pharmacy distribution partner for Leqembi (lecanemab-irmb), a newly FDA-approved treatment for early and mild stages of Alzheimer’s Disease. Soleo Health CEO Drew Walk says the partnership "will afford the Alzheimer’s community continued hope while we assist patients and their caregivers as they navigate their healthcare journey."
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.